{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:30:19Z","timestamp":1742801419130},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:00:00Z","timestamp":1400716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00063-013-0339-7","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T11:06:42Z","timestamp":1400584002000},"page":"336-341","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zitratantikoagulation in der akuten Nierenersatztherapie"],"prefix":"10.1007","volume":"109","author":[{"given":"R.D.","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"339_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/j.ajkd.2004.12.002","volume":"45","author":"Apsner","year":"2005","unstructured":"Apsner R, Buchmayer H, Gruber D, Sunder-Plassmann G (2005) Citrate for long-term hemodialysis: a prospective study of 1009 consecutive high-flux treatments in 59 patients. Am J Kidney Dis 45:557\u2013564","journal-title":"Am J Kidney Dis"},{"key":"339_CR2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1213\/01.ANE.0000132780.87036.F5","volume":"99","author":"Apsner","year":"2004","unstructured":"Apsner R, Gruber D, H\u00f6rl WH, Sunder-Plassmann G (2004) Parathyroid hormone secretion during citrate anticoagulated hemodialysis in acutely ill maintenance hemodialysis patients. Anesth Analg 99:1199\u20131204","journal-title":"Anesth Analg"},{"key":"339_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcrc.2005.01.001","volume":"20","author":"Bagshaw","year":"2005","unstructured":"Bagshaw SM, Laupland KB, Boiteau PJE, Godinez-Luna T (2005) Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 20:155\u2013161","journal-title":"J Crit Care"},{"key":"339_CR4","first-page":"602","volume":"20","author":"Betjes","year":"2007","unstructured":"Betjes MG, Oosterom D van, Agteren M van, Wetering J van de (2007) Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol 20:602\u2013608","journal-title":"J Nephrol"},{"key":"339_CR5","first-page":"72","volume":"13","author":"Brain","year":"2011","unstructured":"Brain M, Parkes S, Fowler P et al (2011) Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc 13:72\u201381","journal-title":"Crit Care Resusc"},{"key":"339_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000046075","volume":"89","author":"Calatzis","year":"2001","unstructured":"Calatzis A, Toepfer M, Schramm W et al (2001) Citrate Anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 89:233\u2013236","journal-title":"Nephron"},{"key":"339_CR7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.ajkd.2007.02.001","volume":"49","author":"Evenepoel","year":"2007","unstructured":"Evenepoel P, Dejagere T, Verhamme P et al (2007) Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Am J Kidney Dis 49:642\u2013649","journal-title":"Am J Kidney Dis"},{"key":"339_CR8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00134-002-1443-y","volume":"28","author":"Gabutti","year":"2002","unstructured":"Gabutti L, Marone C, Colucci G et al (2002) Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28:1419\u20131425","journal-title":"Intensive Care Med"},{"key":"339_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/gfi069","volume":"21","author":"Gritters","year":"2006","unstructured":"Gritters M, Grooteman MPC, Schoorl M et al (2006) Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 21:153\u2013159","journal-title":"Nephrol Dial Transplant"},{"key":"339_CR10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.ajkd.2006.07.016","volume":"48","author":"Hetzel","year":"2006","unstructured":"Hetzel GR, Taskaya G, Sucker C et al (2006) Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 48:806\u2013811","journal-title":"Am J Kidney Dis"},{"key":"339_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ndt\/gfq575","volume":"26","author":"Hetzel","year":"2011","unstructured":"Hetzel GR, Schmitz M, Wissing H et al (2011) Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26:232\u2013239","journal-title":"Nephrol Dial Transplant"},{"key":"339_CR12","doi-asserted-by":"crossref","unstructured":"Khadzhynov D, Schelter C, Lieker I et al (2013) Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care (epub ahead of print)","DOI":"10.1016\/j.jcrc.2013.10.015"},{"key":"339_CR13","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/ndt\/gfp017","volume":"24","author":"Kozik-Jaromin","year":"2009","unstructured":"Kozik-Jaromin J, Nier V, Heemann U et al (2009) Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 24:2244\u20132251","journal-title":"Nephrol Dial Transplant"},{"key":"339_CR14","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","volume":"31","author":"Kramer","year":"2003","unstructured":"Kramer L, Bauer E, Joukhadar C et al (2003) Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 31:2450\u20132455","journal-title":"Crit Care Med"},{"key":"339_CR15","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1523-1755.2005.00342.x","volume":"67","author":"Kutsogiannis","year":"2005","unstructured":"Kutsogiannis DJ, Noel Gibney RT, Stollery D, Gao J (2005) Regional citrate versus systemic heparin anticoagulation for continous renal replacement in critically ill patients. Kidney Int 67:2361\u20132367","journal-title":"Kidney Int"},{"key":"339_CR16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00134-010-1909-2","volume":"36","author":"Mariano","year":"2010","unstructured":"Mariano F, Tedeschi L, Morselli M et al (2010) Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 36:1735\u20131743","journal-title":"Intensive Care Med"},{"key":"339_CR17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","volume":"29","author":"Meier-Kriesche","year":"2001","unstructured":"Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T (2001) Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29:748\u2013752","journal-title":"Crit Care Med"},{"key":"339_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","volume":"30","author":"Monchi","year":"2004","unstructured":"Monchi M, Berghmans D, Ledoux D et al (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30:260\u2013265","journal-title":"Intensive Care Med"},{"key":"339_CR19","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/CCM.0b013e3181a00a92","volume":"37","author":"Morgera","year":"2009","unstructured":"Morgera S, Schneider M, Slowinski T et al (2009) A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 37:2018\u20132024","journal-title":"Crit Care Med"},{"key":"339_CR20","doi-asserted-by":"crossref","first-page":"c131","DOI":"10.1159\/000079171","volume":"97","author":"Morgera","year":"2004","unstructured":"Morgera S, Scholle C, Voss G et al (2004) Metabolic complications during regional citrate anticoagulation in continous venovenous hemodialysis: single-center experience. Nephron Clin Pract 97:c131\u2013c136","journal-title":"Nephron Clin Pract"},{"key":"339_CR21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","volume":"37","author":"Oudemans-van","year":"2009","unstructured":"Oudemans-van Straaten HM, Bosman RJ, Koopmans M et al (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37:545\u2013552","journal-title":"Crit Care Med"},{"key":"339_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3904\/kjim.2011.26.1.68","volume":"26","author":"Park","year":"2011","unstructured":"Park JS, Kim GH, Kang CM, Lee CH (2011) Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration. Korean J Intern Med 26:68\u201375","journal-title":"Korean J Intern Med"},{"key":"339_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000355860","volume":"124","author":"Raimundo","year":"2013","unstructured":"Raimundo M, Crichton S, Lei K et al (2013) Maintaining normal levels of ionized calcium during citrate-based renal replacement therapy is associated with stable parathyroid hormone levels. Nephron Clin Pract 124:124\u2013131","journal-title":"Nephron Clin Pract"},{"key":"339_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1525-1594.2010.01038.x","volume":"35","author":"Richtrova","year":"2011","unstructured":"Richtrova P, Rulcova K, Mares J, Reischig T (2011) Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect. Artif Organs 35:83\u201388","journal-title":"Artif Organs"},{"key":"339_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2369-15-19","volume":"15","author":"Schilder","year":"2014","unstructured":"Schilder L, Nurmohamed SA, Ter Wee PT et al (2014) Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients. BMC Nephrol 15:19","journal-title":"BMC Nephrol"},{"key":"339_CR26","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1186\/cc11485","volume":"16","author":"Schulthei\u00df","year":"2012","unstructured":"Schulthei\u00df C, Saugel B, Philip V et al (2012) Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 16:R162","journal-title":"Crit Care"},{"key":"339_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.MAT.0000104822.30759.A7","volume":"50","author":"Uchino","year":"2004","unstructured":"Uchino S, Fealy N, Baldwin I et al (2004) Continuous venovenous hemofiltration without anticoagulation. ASAIO J 50:76\u201380","journal-title":"ASAIO J"},{"key":"339_CR28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","volume":"294","author":"Uchino","year":"2005","unstructured":"Uchino S, Kellum JA, Bellomo R et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813\u2013818","journal-title":"JAMA"},{"key":"339_CR29","first-page":"580","volume":"50","author":"Zick","year":"2009","unstructured":"Zick G, Wilms C, Renders L et al (2009) Continuous renal replacement therapy with regional citrate anticoagulation in patients with liver failure \u2013 a prospective observational study. An\u00e4sth Intensivmed 50:580\u2013591","journal-title":"An\u00e4sth Intensivmed"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0339-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-013-0339-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-013-0339-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T16:50:12Z","timestamp":1565455812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-013-0339-7"}},"subtitle":["Methode der Wahl"],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1007\/s00063-013-0339-7","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}